Abstract
Favorable Response of Advanced Superior Sulcus Non-Small Cell Lung Carcinoma to Gefitinib for 11 years complicated by Interval Development of Small Cell Carcinoma of the Lung
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have